CORFEN DM - chlorpheniramine maleate, dextromethorphan hydrobromide and phenylephrine hydrochloride liquid 
Cypress Pharmaceutical, Inc.

----------

CORFEN-DM Liquid

DRUG FACTS

Active ingredients                    Purpose
(in each 5 mL teaspoonful)

Chlorpheniramine Maleate 4mg................ Antihistamine
Dextromethorphan Hydrobromide 15mg.....Cough Suppressant
Phenylephrine Hydrochloride 10mg...........Nasal Decongestant

Uses

temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or
other upper respiratory allergies:
•runny nose •sneezing •itching of the nose or throat •itchy, watery eyes •cough due to minor
throat and bronchial irritation •nasal congestion •reduces swelling of nasal passages

Warnings

Do not exceed recommended dosage.

Do not use this product

•if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for
depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks
after stopping the MAOI drug. If you do now know if your prescription drug contains an
MAOI, ask a doctor or pharmacists before taking this product

Ask a doctor before use if you have

•a breathing problem such as emphysema or chronic bronchitis •glaucoma •trouble urinating
due to an enlarged prostate gland •a cough that lasts or is chronic such as occurs with
smoking, asthma or emphysema •a cough that occurs with too much phlegm (mucus)
•heart disease •high blood pressure •thyroid disease •diabetes mellitus

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers.

When using this product

•excitability may occur, especially in children •may cause marked drowsiness •avoid alcoholic
drinks •alcohol, sedatives, and tranquilizers may increase drowsiness •be careful when driving
a motor vehicle or when operating machinery

Stop use and ask a doctor if

•nervousness, dizziness, or sleeplessness occur •cough or nasal congestion persists for more
than 1 week, tends to recur, or is accompanied by a fever, rash or persistent headache. These
could be signs of a serious condition. •new symptoms occur

If pregnant or breast-feeding,

ask a health professional before use.

Keep this and all drugs out of the reach of children.

In case of accidental overdose, get medical help or contact a Poison Control Center right away.

Directions

Do not exceed 6 doses in a 24 hour period.


Adults and children 12 years of age and over:
1 teaspoonful (5 mL) every 4-6 hours as needed.
Children 6 to under 12 years of age:
1/2 teaspoonful (2.5 mL) every 4-6 hours as needed.
Children under 6 years of age:
Consult a physician.

Other information

Store at 77oF (25oC), excursions permitted; 15o - 30oC (59o - 86oF)

Inactive ingredients

Citric Acid, Glycerin, Grape Flavor, Propylene Glycol, Purified Water, Sodium Citrate, Sodium
Saccharin, and Sorbitol.

Questions? Comments?

1-800-856-4393
M-F: 8:00a.m. - 5:00p.m. CT
Serious side effects associated with use of this product may be reported to this number.


Manufactured for:
Cypress Pharmaceutical, Inc.
Madison, MS 39110

PRODUCT PACKAGING





CORFEN-DM Liquid



























Corfen DM Packaging


Corfen DM Packaging

Corfen DM Packaging



CORFEN  DM
chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride   liquid
Product Information
Product Type HUMAN OTC DRUG NDC Product Code (Source) 60258-238
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Chlorpheniramine Maleate (Chlorpheniramine) Chlorpheniramine Maleate 4 mg  in 5 mL
Dextromethorphan Hydrobromide (Dextromethorphan) Dextromethorphan Hydrobromide 15 mg  in 5 mL
Phenylephrine Hydrochloride (Phenylephrine) Phenylephrine Hydrochloride 10 mg  in 5 mL
Inactive Ingredients
Ingredient Name Strength
No Inactive Ingredients Found
Product Characteristics
Color      Score     
Shape Size
Flavor GRAPE Imprint Code
Contains     
Packaging
# NDC Package Description Multilevel Packaging
1 60258-238-16 473 mL In 1 BOTTLE None

Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part341 07/01/2003

Labeler - Cypress Pharmaceutical, Inc. (790248942)
Revised: 07/2009 Cypress Pharmaceutical, Inc.